These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 36127398)
1. ARHGAP-RhoA signaling provokes homotypic adhesion-triggered cell death of metastasized diffuse-type gastric cancer. Komatsu M; Ichikawa H; Chiwaki F; Sakamoto H; Komatsuzaki R; Asaumi M; Tsunoyama K; Fukagawa T; Matsushita H; Boku N; Matsusaki K; Takeshita F; Yoshida T; Sasaki H Oncogene; 2022 Oct; 41(43):4779-4794. PubMed ID: 36127398 [TBL] [Abstract][Full Text] [Related]
2. Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancer. Zhang F; Sahu V; Peng K; Wang Y; Li T; Bala P; Aitymbayev D; Sahgal P; Schaefer A; Der CJ; Ryeom S; Yoon S; Sethi N; Bass AJ; Zhang H Gut; 2024 Jul; 73(8):1280-1291. PubMed ID: 38621923 [TBL] [Abstract][Full Text] [Related]
3. Suppression of BMX-ARHGAP fusion gene inhibits epithelial-mesenchymal transition in gastric cancer cells via RhoA-mediated blockade of JAK/STAT axis. Xu XF; Wang JJ; Ding L; Ye JS; Huang LJ; Tao L; Gao F; Ji Y J Cell Biochem; 2019 Jan; 120(1):439-451. PubMed ID: 30216523 [TBL] [Abstract][Full Text] [Related]
4. RHOA mutations and CLDN18-ARHGAP fusions in intestinal-type adenocarcinoma with anastomosing glands of the stomach. Hashimoto T; Ogawa R; Tang TY; Yoshida H; Taniguchi H; Katai H; Oda I; Sekine S Mod Pathol; 2019 Apr; 32(4):568-575. PubMed ID: 30425335 [TBL] [Abstract][Full Text] [Related]
5. Gain-of-Function Zhang H; Schaefer A; Wang Y; Hodge RG; Blake DR; Diehl JN; Papageorge AG; Stachler MD; Liao J; Zhou J; Wu Z; Akarca FG; de Klerk LK; Derks S; Pierobon M; Hoadley KA; Wang TC; Church G; Wong KK; Petricoin EF; Cox AD; Lowy DR; Der CJ; Bass AJ Cancer Discov; 2020 Feb; 10(2):288-305. PubMed ID: 31771969 [TBL] [Abstract][Full Text] [Related]
6. RhoA/ROCK/ARHGAP26 signaling in the eutopic and ectopic endometrium is involved in clinical characteristics of adenomyosis. Jiang C; Gong W; Chen R; Ke H; Qu X; Yang W; Cheng Z J Int Med Res; 2018 Dec; 46(12):5019-5029. PubMed ID: 30387365 [TBL] [Abstract][Full Text] [Related]
7. Advanced glycosylation end products (AGEs) controls proliferation, invasion and permeability through orchestrating ARHGAP18/RhoA pathway in human umbilical vein endothelial cells. Li X; Tao Y; Wang X; Wang T; Liu J Glycoconj J; 2020 Apr; 37(2):209-219. PubMed ID: 32016689 [TBL] [Abstract][Full Text] [Related]
8. Plakophilin 4 controls the spatio-temporal activity of RhoA at adherens junctions to promote cortical actin ring formation and tissue tension. Müller L; Keil R; Glaß M; Hatzfeld M Cell Mol Life Sci; 2024 Jul; 81(1):291. PubMed ID: 38970683 [TBL] [Abstract][Full Text] [Related]
9. Recurrent Fusion Genes in Gastric Cancer: CLDN18-ARHGAP26 Induces Loss of Epithelial Integrity. Yao F; Kausalya JP; Sia YY; Teo AS; Lee WH; Ong AG; Zhang Z; Tan JH; Li G; Bertrand D; Liu X; Poh HM; Guan P; Zhu F; Pathiraja TN; Ariyaratne PN; Rao J; Woo XY; Cai S; Mulawadi FH; Poh WT; Veeravalli L; Chan CS; Lim SS; Leong ST; Neo SC; Choi PS; Chew EG; Nagarajan N; Jacques PÉ; So JB; Ruan X; Yeoh KG; Tan P; Sung WK; Hunziker W; Ruan Y; Hillmer AM Cell Rep; 2015 Jul; 12(2):272-85. PubMed ID: 26146084 [TBL] [Abstract][Full Text] [Related]
10. Xenopus Kazrin interacts with ARVCF-catenin, spectrin and p190B RhoGAP, and modulates RhoA activity and epithelial integrity. Cho K; Vaught TG; Ji H; Gu D; Papasakelariou-Yared C; Horstmann N; Jennings JM; Lee M; Sevilla LM; Kloc M; Reynolds AB; Watt FM; Brennan RG; Kowalczyk AP; McCrea PD J Cell Sci; 2010 Dec; 123(Pt 23):4128-44. PubMed ID: 21062899 [TBL] [Abstract][Full Text] [Related]
12. RHOA mutation in diffuse-type gastric cancer: a comparative clinicopathology analysis of 87 cases. Ushiku T; Ishikawa S; Kakiuchi M; Tanaka A; Katoh H; Aburatani H; Lauwers GY; Fukayama M Gastric Cancer; 2016 Apr; 19(2):403-411. PubMed ID: 25823974 [TBL] [Abstract][Full Text] [Related]
13. Functional analysis of ARHGAP6, a novel GTPase-activating protein for RhoA. Prakash SK; Paylor R; Jenna S; Lamarche-Vane N; Armstrong DL; Xu B; Mancini MA; Zoghbi HY Hum Mol Genet; 2000 Mar; 9(4):477-88. PubMed ID: 10699171 [TBL] [Abstract][Full Text] [Related]
14. Cadherin engagement inhibits RhoA via p190RhoGAP. Noren NK; Arthur WT; Burridge K J Biol Chem; 2003 Apr; 278(16):13615-8. PubMed ID: 12606561 [TBL] [Abstract][Full Text] [Related]
15. Hypoxia-induced ARHGAP26 deficiency inhibits the proliferation and migration of human ductus arteriosus smooth muscle cell through activating RhoA-ROCK-PTEN pathway. Li M; Ye L; Ye X; Wang S; Zhang H; Liu J; Hong H J Cell Biochem; 2019 Jun; 120(6):10106-10117. PubMed ID: 30592323 [TBL] [Abstract][Full Text] [Related]
16. RhoA mutations identified in diffuse gastric cancer. Zhou J; Hayakawa Y; Wang TC; Bass AJ Cancer Cell; 2014 Jul; 26(1):9-11. PubMed ID: 25026207 [TBL] [Abstract][Full Text] [Related]
19. Arhgap28 is a RhoGAP that inactivates RhoA and downregulates stress fibers. Yeung CY; Taylor SH; Garva R; Holmes DF; Zeef LA; Soininen R; Boot-Handford RP; Kadler KE PLoS One; 2014; 9(9):e107036. PubMed ID: 25211221 [TBL] [Abstract][Full Text] [Related]
20. Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers. Cho SY; Park JW; Liu Y; Park YS; Kim JH; Yang H; Um H; Ko WR; Lee BI; Kwon SY; Ryu SW; Kwon CH; Park DY; Lee JH; Lee SI; Song KS; Hur H; Han SU; Chang H; Kim SJ; Kim BS; Yook JH; Yoo MW; Kim BS; Lee IS; Kook MC; Thiessen N; He A; Stewart C; Dunford A; Kim J; Shih J; Saksena G; Cherniack AD; Schumacher S; Weiner AT; Rosenberg M; Getz G; Yang EG; Ryu MH; Bass AJ; Kim HK Gastroenterology; 2017 Aug; 153(2):536-549.e26. PubMed ID: 28522256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]